Brucke Financial’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,567
Closed -$153K 181
2026
Q1
$153K Buy
+10,567
New +$151K 0.08% 164

Other funds holding FOLD

Brucke Financial's FOLD Position: Q2 2026 in Review

Brucke Financial sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 10,567 shares — an estimated $153K sold.

Brucke Financial first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $153K in Q1 2026. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

  • Brucke Financial reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Brucke Financial sold 10,567 Amicus Therapeutics shares in Q2 2026, an estimated $153K.
  • Brucke Financial first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
  • Brucke Financial's Amicus Therapeutics position peaked at $153K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Brucke Financial's 13F filing for Q2 2026, filed 21 Jul 2026.